GALILEO
Report
- Report Number
- 1034569-2008-00513
- Event Type
- Malfunction
- Date Received
- October 21, 2008
- Date of Event
- September 26, 2008
- Report Date
- October 10, 2008
- Manufacturer
- IMMUCOR, INC.
- Product Code
- KSZ
- PMA / PMN Number
- BK040013
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
ABORH TESTING WAS PERFORMED WITH IN-HOUSE DONOR SAMPLES OF KNOWN ABO/RH TYPES, USING RETENTION ANTI-A, LOT 101676, AND ANTI-B SERIES 3, LOT 203224, ON IN-HOUSE GALILEO. THESE REAGENTS WERE USED AT THE TIME OF THE EVENT. A1 REFERENCELL, LOT 111664, AND B REFERENCELL, LOT 113664, WERE USED FOR REVERSE GROUPING. ALL IN-HOUSE DONOR SAMPLES TYPED AS EXPECTED. ABORH TESTING WAS PERFORMED WITH THE CUSTOMER'S RETURNED DONOR SAMPLE, USING RETENTION ANTI-A, LOT 101676, AND ANTI-B SERIES 3, LOT 203224, ON AN IN-HOUSE GALILEO. A1 REFERENCELL, LOT 111664, AND B REFERENCELL, LOT 113664, WERE USED FOR REVERSE GROUPING. THE SAMPLE WAS INTERPRETED AS B-POSITIVE. HEMAGGLUTINATION TUBE TESTING WAS PERFORMED WITH THE CUSTOMER'S DONOR SAMPLE, USING RETENTION ANTI-A, LOT 101676, AND ANTI-B SERIES 3, LOT 203224. A1 REFERENCELL, LOT 111668, A2 REFERENCELL, LOT 112566, B REFERENCELL, LOT 113668 R, AND O REFERENCELL, LOT 114072, WERE USED FOR REVERSE GROUPING. THE SAMPLE EXHIBITED 4+ REACTIVITY WITH ANTI-B AND 1+ REACTIVITY WITH A1 REFERENCELLS AT IS. THE SAMPLE WAS INCUBATED AT RT WITH ANTI-A FOR 60-MINUTES;IT EXHIBITED 1+ MIXED-FIELD REACTIVITY. THE GALILEO OPERATOR MANUAL INDICATES THAT THE GALILEO DOES NOT DIFFERENTIATE MIXED FIELD REACTIONS.
CUSTOMER REPORTS THAT A DONOR SAMPLE WAS TESTED ON THE GALILEO AND RESULTED AS B POSITIVE. THE UNIT HAD BEEN LABELED AS A B POSITIVE UNIT. IT WAS SENT OUT TO A HOSPITAL; THE UNIT SEGMENT THEY TESTED RESULTED AS AB POSITIVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GALILEO | AUTOMATED BLOOD BANK ANALYZER | KSZ | IMMUCOR, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |